Retinoblastoma research projects
Retinoblastoma (Rb) is the most common eye cancer in children globally. The cancer develops from cells of the retina (back of the eye), and 80% of patients with retinoblastoma reside in low-income and middle-income countries in Africa, Asia, and Latin America.
In high-income countries the survival rate for Rb is nearly 100%, but until recently there was little research from low and middle-income countries (LMICs).
The Global Retinoblastoma Study Group
The Global Retinoblastoma Study Group (GRSG), brings together experts from over 150 countries and more than 450 centres worldwide, facilitating large-scale research.
The Retinoblastoma Network
The Retinoblastoma Network (Rb-NET) is a collaborative group of Rb treatment centres that share skills and knowledge around the world
Treatment for Advanced Retinoblastoma in LMICs – The TopCAT Trial
A study by researchers at the International Centre for Eye Health will evaluate a new treatment regime for children with advanced Rb in Tanzania.
Retinoblastoma Research Projects
Retinoblastoma (Rb) is the most common eye cancer in children globally. The cancer develops from cells of the retina (back of the eye), and 80% of patients with retinoblastoma reside in low-income and middle-income countries in Africa, Asia, and Latin America.
In high-income countries the survival rate for Rb is nearly 100%, but until recently there was little research from low and middle-income countries (LMICs).
The Global Retinoblastoma Study Group
The Global Retinoblastoma Study Group (GRSG), brings together experts from over 150 countries and more than 450 centres worldwide, facilitating large-scale research.
The Retinoblastoma Network
The Retinoblastoma Network (Rb-NET) is a collaborative group of Rb treatment centres that share skills and knowledge around the world
Treatment for Advanced Retinoblastoma in LMICs – The TopCAT Trial
A study by researchers at the International Centre for Eye Health will evaluate a new treatment regime for children with advanced Rb in Tanzania.